Developing methodologies to evaluate benefits and costs of Arterial Spin Labeling in Alzheimer's Disease
暂无分享,去创建一个
Manuel T. Rodrigues | Monica D. Oliveira | M. T. Pena | M. Rodrigues | M. Oliveira | M. T. Pena | Monica D. Oliveira | M. T. Pena
[1] Linus Jönsson,et al. The Cost of Dementia in Europe , 2012, PharmacoEconomics.
[2] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[3] S. O'Bryant,et al. The Arsenic Exposure Hypothesis for Alzheimer Disease , 2010, Alzheimer disease and associated disorders.
[4] V. Cruz,et al. Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal , 2010, BMC neurology.
[5] E. D. Schwartz,et al. Initial Experience in Using Continuous Arterial Spin-Labeled MR Imaging for Early Detection of Alzheimer Disease , 2010, American Journal of Neuroradiology.
[6] R. Chapman,et al. Please Scroll down for Article Journal of Clinical and Experimental Neuropsychology Diagnosis of Alzheimer's Disease Using Neuropsychological Testing Improved by Multivariate Analyses , 2022 .
[7] Alexander Drzezga,et al. Amyloid-plaque imaging in early and differential diagnosis of dementia , 2010, Annals of nuclear medicine.
[8] Norbert Schuff,et al. ASL Perfusion MRI Predicts Cognitive Decline and Conversion From MCI to Dementia , 2010, Alzheimer disease and associated disorders.
[9] David C. Alsop,et al. Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging , 2010, Neuroradiology.
[10] Norbert Schuff,et al. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging , 2009, Alzheimer's & Dementia.
[11] James T Becker,et al. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.
[12] L. García-Pérez,et al. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[13] Charles Bridges-Webb,et al. The pathway to dementia diagnosis , 2008, The Medical journal of Australia.
[14] K. Lapane,et al. Dementia of the Alzheimer type. , 2008, Epidemiologic reviews.
[15] David C. Alsop,et al. Hippocampal hyperperfusion in Alzheimer's disease , 2008, NeuroImage.
[16] J. Guérit,et al. Harrison's principles of internal medicine, McGraw Hill New York (1998) pp.2570. , 2008 .
[17] Joshua T. Cohen,et al. Decision analytic models for Alzheimer's disease: State of the art and future directions , 2008, Alzheimer's & Dementia.
[18] Yaakov Stern,et al. Multivariate and Univariate Analysis of Continuous Arterial Spin Labeling Perfusion MRI in Alzheimer's Disease , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] Marc Korczykowski,et al. Imaging mesial temporal lobe activation during scene encoding: Comparison of fMRI using BOLD and arterial spin labeling , 2007, Human brain mapping.
[20] S. Lovestone,et al. Diagnosing Alzheimer's disease—non‐clinicians and computerised algorithms together are as accurate as the best clinical practice , 2007, International journal of geriatric psychiatry.
[21] C. DeCarli,et al. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? , 2007, Neurology.
[22] J. Jolles,et al. Symptoms of Preclinical Dementia in General Practice up to Five Years before Dementia Diagnosis , 2007, Dementia and Geriatric Cognitive Disorders.
[23] M. Aalabaf-Sabaghi. Decision modelling for health economic evaluation , 2007, Journal of Epidemiology and Community Health.
[24] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[25] Bruce L. Miller,et al. Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology , 2007 .
[26] Christopher C Rowe,et al. Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease , 2007, Journal of Nuclear Medicine.
[27] Stefan J. Teipel,et al. Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease , 2007, European Archives of Psychiatry and Clinical Neuroscience.
[28] N. Balak,et al. Costs of disorders of the brain in Europe , 2007, European journal of neurology.
[29] P. Scheltens,et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline , 2007, European journal of neurology.
[30] Helena Lindgren,et al. Decision support in dementia care: developing systems for interactive reasoning , 2007 .
[31] L. Perestelo-Pérez,et al. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain , 2006, Neurology.
[32] Can dynamic susceptibility contrast magnetic resonance imaging replace single-photon emission computed tomography in the diagnosis of patients with alzheimer's disease? a pilot study , 2006, Acta radiologica.
[33] M. Drummond. Pharmacoeconomics: friend or foe? , 2006, Annals of the rheumatic diseases.
[34] N. Schuff,et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI , 2006, Neurology.
[35] Marta Indulska,et al. How do practitioners use conceptual modeling in practice? , 2006, Data Knowl. Eng..
[36] X Golay,et al. Non-invasive Measurement of Perfusion: a Critical Review of Arterial Spin Labelling Techniques , 2022 .
[37] M. Wintermark,et al. Comparative overview of brain perfusion imaging techniques. , 2005, Stroke.
[38] S. Vilas,et al. Avaliação Económica da Terapêutica e do Suporte Não Farmacológico da Doença de Alzheimer , 2005 .
[39] M. Chong,et al. Preclinical Alzheimer's disease: diagnosis and prediction of progression , 2005, The Lancet Neurology.
[40] M. Wintermark,et al. Comparative Overview of Brain Perfusion Imaging Techniques , 2005, Journal of neuroradiology. Journal de neuroradiologie.
[41] C. Berr,et al. Cost of dementia in Europe , 2005, European journal of neurology.
[42] N. Schuff,et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.
[43] E. Mori,et al. Effectiveness of a clinical pathway for the diagnosis and treatment of dementia and for the education of families , 2004, International journal of geriatric psychiatry.
[44] H. Feldman,et al. Economic evaluation of donepezil in moderate to severe Alzheimer disease , 2004, Neurology.
[45] G. Samsa,et al. Alzheimer disease: operating characteristics of PET--a meta-analysis. , 2004, Radiology.
[46] Nikos K Logothetis,et al. Interpreting the BOLD signal. , 2004, Annual review of physiology.
[47] Donald L Bliwise,et al. Sleep disorders in Alzheimer's disease and other dementias. , 2004, Clinical cornerstone.
[48] S. Filipek,et al. Genetic aspects of Alzheimer's disease. , 2004, Acta neurobiologiae experimentalis.
[49] M. D’Esposito,et al. Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging , 2003, Nature Reviews Neuroscience.
[50] When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysis. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[51] G. Gazelle,et al. Cost-effectiveness of PET in the diagnosis of Alzheimer disease. , 2003, Radiology.
[52] M. Gould,et al. The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centers. , 2003, AJR. American journal of roentgenology.
[53] C. Zimmer,et al. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. , 2003, Radiology.
[54] Bennett P Leifer. Early Diagnosis of Alzheimer's Disease: Clinical and Economic Benefits , 2003, Journal of the American Geriatrics Society.
[55] A. Webb,et al. Introduction to biomedical imaging , 2002 .
[56] J. L. Pinto,et al. [What is an efficient health technology in Spain?]. , 2002, Gaceta sanitaria.
[57] J. A. Sacristán,et al. Qué es una tecnología sanitaria eficiente en España , 2002 .
[58] Sanjiv S Gambhir,et al. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[59] Stephen M. Smith,et al. Functional MRI : an introduction to methods , 2002 .
[60] G. Alexander,et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.
[61] R. Floris,et al. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. , 2001, AJNR. American journal of neuroradiology.
[62] B. Miller,et al. CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .
[63] G. Samsa,et al. Use of Positron Emission Tomography and Other Neuroimaging Techniques in the Diagnosis and Management of Alzheimer’s Disease and Dementia , 2001 .
[64] M C Weinstein,et al. Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease. , 2001, International journal of technology assessment in health care.
[65] J. Hoffman,et al. FDG PET imaging in patients with pathologically verified dementia. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] G. Gazelle,et al. Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease. , 2000, Radiology.
[67] D. Weinberger,et al. Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST) , 2000, Magnetic resonance in medicine.
[68] J. Detre,et al. Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.
[69] Seong-Gi Kim,et al. Pseudo‐continuous arterial spin labeling technique for measuring CBF dynamics with high temporal resolution , 1999, Magnetic resonance in medicine.
[70] P Lindgren,et al. The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model. , 1999, Clinical therapeutics.
[71] Linda Teri,et al. Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.
[72] Michael E. Phelps,et al. Clinical Value of Neuroimaging in the Diagnosis of Dementia. Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's Disease. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[73] J. Detre,et al. Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. , 1999, European journal of radiology.
[74] L. Kurlowicz,et al. The Mini Mental State Examination (MMSE). , 1999, Director.
[75] L. Williams,et al. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease , 1999, Neurology.
[76] D. Coon,et al. The personal and social consequences of Alzheimer disease. , 1999, Genetic testing.
[77] P J Neumann,et al. Alzheimer's disease care: costs and potential savings. , 1998, Health affairs.
[78] P F Renshaw,et al. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. , 1998, AJNR. American journal of neuroradiology.
[79] G. Small,et al. An economic evaluation of donepezil in the treatment of Alzheimer's disease. , 1998, Clinical therapeutics.
[80] J Raftery,et al. Perspectives in economic evaluation , 1998, BMJ.
[81] P. Renshaw,et al. Dynamic susceptibility contrast MR imaging for the evaluation of probable Alzheimer disease: a cost-effectiveness analysis. , 1998, Academic radiology.
[82] R. Mohs,et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease , 1998, Neurology.
[83] H. Braak,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[84] Seong‐gi Kim Cmrr,et al. Comparison of blood oxygenattion and cerebral blood flow effect in fMRI: Estimation of relative oxygen consumption change , 1997, Magnetic resonance in medicine.
[85] D. Geldmacher,et al. Differential diagnosis of Alzheimer's disease , 1997, Neurology.
[86] P. Renshaw,et al. Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in alzheimer's disease: A principal components analysis , 1997, Journal of magnetic resonance imaging : JMRI.
[87] D Comar,et al. Differential diagnosis of Alzheimer's disease with PET. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[88] A Briggs,et al. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. , 1994, Health economics.
[89] M. Folstein,et al. Population-based norms for the Mini-Mental State Examination by age and educational level. , 1993, JAMA.
[90] W W Hauck,et al. The economic burden of Alzheimer's disease care. , 1993, Health affairs.
[91] Ravi S. Menon,et al. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. , 1993, Biophysical journal.
[92] Donald S. Williams,et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[93] D. Tank,et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[94] Gesamtverband Deutscher Nervenärzte. European archives of psychiatry and clinical neuroscience , 1990 .
[95] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.
[96] M. Folstein,et al. Mini-Mental State Examination (MMSE) , 2019, Encyclopedia of Gerontology and Population Aging.
[97] J. Bigby. Harrison's Principles of Internal Medicine , 1988 .
[98] C. Filley. Diagnosis of Alzheimer's disease. , 1988, Colorado medicine.
[99] R. Ernst,et al. The economic costs of Alzheimer's disease. , 1987, American journal of public health.
[100] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[101] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[102] M. Folstein,et al. The Mini-Mental State Examination. , 1983, Archives of general psychiatry.
[103] R. Adams,et al. Principles of Neurology , 1996 .